BioXcel Therapeutics (BTAIQ) EBITDA (2017 - 2026)
BioXcel Therapeutics (BTAIQ) reported EBITDA of -$10.18 million for Q2 2026, compared with -$15.78 million a year earlier.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) EBITDA (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioXcel Therapeutics' EBITDA came in at -$44.7 million; for FY2025, it came in at -$50.16 million.
- By year, EBITDA came in at -$66.94 million in FY2024, -$171.46 million in FY2023, -$159.32 million in FY2022 and -$106.64 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$52.81 million in Q4 2022 and a high of -$10.02 million in Q1 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$10.17 million (Q1 2026), -$10.21 million (Q4 2025) and -$14.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.10 Bn | 1,100.69 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.67 Bn | 534.20 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 504.61 Bn | 477.72 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.03 Bn | 322.41 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.24 Bn | 262.23 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.77 Bn | 235.46 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.81 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | BioXcel Therapeutics | 415,110.00 | -94.20 Mn | 160,000.00 | -9.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.40 Mn |
| Mar 31, 2026 | -9.66 Mn |
| Dec 31, 2025 | -9.74 Mn |
| Sep 30, 2025 | -13.71 Mn |
| Jun 30, 2025 | -15.38 Mn |
| Mar 31, 2025 | -9.67 Mn |
| Dec 31, 2024 | -10.19 Mn |
| Sep 30, 2024 | -15.11 Mn |
| Jun 30, 2024 | -17.12 Mn |
| Mar 31, 2024 | -24.04 Mn |
| Dec 31, 2023 | -19.49 Mn |
| Sep 30, 2023 | -47.84 Mn |
| Jun 30, 2023 | -51.98 Mn |
| Mar 31, 2023 | -50.79 Mn |
| Dec 31, 2022 | -52.49 Mn |
| Sep 30, 2022 | -38.69 Mn |
| Jun 30, 2022 | -35.88 Mn |
| Mar 31, 2022 | -31.40 Mn |
| Dec 31, 2021 | -26.06 Mn |
| Sep 30, 2021 | -26.74 Mn |
API Access
BioXcel Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();